Evidence map›Paper›PMID 29806444›Full record

ReviewZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2017

[Research progress in osteogenesis and osteogenic mechanism of heparan sulfate].

Zhujie Xu, Jinghua Chen, Wei Shao, Rui Wang, Yi Liu

Open access · greenAbstract readReview
In one paragraph

Review in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zhujie XuDepartment of Orthopedics, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi Jiangsu, 214000, P.R.China.
Jinghua ChenMedicinal Biopolymer Laboratory of College of Pharmacy, Jiangnan University, Wuxi Jiangsu, 214000, P.R.China.
Wei ShaoDepartment of Orthopedics, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi Jiangsu, 214000, P.R.China.
Rui WangDepartment of Orthopedics, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi Jiangsu, 214000, P.R.China.
Yi LiuDepartment of Orthopedics, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi Jiangsu, 214000, P.R.China;Medicinal Biopolymer Laboratory of College of Pharmacy, Jiangnan University, Wuxi Jiangsu, 214000, P.R.China.wxryliuyi@126.com.
Wuxi People's Hospital · CNJiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To discuss the role of heparan sulfate (HS) in bone formation and bone remodeling and summarize the research progress in the osteogenic mechanism of HS. Methods: The domestic and abroad related literature about HS acting on osteoblast cell line Results: Many growth factors involved in fracture healing especially heparin-binding growth factors, such as fibroblast growth factors, bone morphogenetic protein, and transforming growth factor β, are connected noncovalently with long HS chains. HS proteoglycans protect these proteins from protease degradation and are directly involved in the regulation of growth factors signaling and bone cell function. HS can promote the differentiation of stem cells into osteoblasts and enhance the differentiation of osteoblasts. In bone matrix, HS plays a significant role in promoting the formation, maintaining the stability, and accelerating the mineralization. Conclusion: The osteogenesis of HS is pronounced. HS is likely to become the clinical treatment measures of fracture nonunion or delayed union, and is expected to provide more choices for bone tissue engineering with identification of its long-term safety.

Indexed as

Bone Morphogenetic ProteinsCell DifferentiationOsteoblastsOsteogenesisBone RemodelingHeparan SulfateHumansBone Morphogenetic ProteinsHeparan Sulfatebone defect repairHeparan sulfateosteogenesisosteogenic mechanismsignaling pathway

Identifiers

PMID29806444
PMCPMC8458588
OpenAlexW2973920440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.